| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Revenue | $193K | -6.8% |
| Cost of Revenue | $27K | +107.7% |
| R&D Expense | $566K | +8.8% |
| SG&A Expense | $9.4M | +302.0% |
| Operating Income | -$9.8M | -268.0% |
| Interest Expense | $447K | -31.7% |
| Net Income | -$17.2M | -70.9% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.1M | +1186.4% |
| Accounts Receivable | $24K | +20.0% |
| Current Assets | $2.1M | +944.8% |
| Total Assets | $2.2M | +495.7% |
| Current Liabilities | $13.6M | -3.7% |
| Total Liabilities | $13.8M | -6.0% |
| Stockholders' Equity | -$10.7M | +25.3% |
| Line Item | 2021-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$3.1M | -35.8% |
| Capital Expenditures | $0 | -100.0% |
| Investing Cash Flow | $0 | +100.0% |
| Financing Cash Flow | $5.0M | +112.7% |
| Free Cash Flow | -$3.1M | -35.7% |